1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
Plaque Psoriasis: Global Drug Forecast and Market Analysis to 2027

Plaque Psoriasis: Global Drug Forecast and Market Analysis to 2027

  • December 2018
  • 106 pages
  • ID: 5761272
  • Format: PDF
  • GlobalData


Table of Contents

Search Inside

Plaque Psoriasis: Global Drug Forecast and Market Analysis to 2027

There is a high level of unmet need that is beginning to be addressed by pharmaceutical companies and this in turn is driving the modest growth of the global Plaque psoriasis market. Global Plaque psoriasis market is expected to grow from $16.2bn in 2017 to $24.2bn in 2027 across the seven major markets (7MM - The US, France, Germany, Italy, Spain, the UK and Japan) at a compound annual growth rate of 4.1%.

Psoriasis is an incurable, chronic and systemic inflammatory skin disorder with a prevalence of 2-3% worldwide.The exact cause of psoriasis is unknown, although it is believed that environmental factors, skin barrier disruptions, and immune dysfunctions are key components that induce the development of psoriasis.

The most common form of psoriasis is plaque psoriasis (psoriasis vulgaris), which is the focus of this report.

The Plaque psoriasis market is currently very dynamic, with novel pipeline therapies being developed. As well as the recent launch of UCB’s Cimzia and Sun Pharma’s Ilumya, will challenge the current tumor necrosis factor (TNF), IL-17 and IL-23 inhibitors, and small molecule compounds.

However, there are still a number of unmet clinical needs in the Plaque psoriasis market, especially relating to the lack of oral therapies and safe topical therapies.These needs have been emphasized by various key opinion leaders (KOLs) interviewed.

Furthermore, KOLs have highlighted that there is a lack of safe and efficacious treatment alternatives for pregnant and breastfeeding women.

Blockbuster drugs such as Amgen’s Enbrel (etanercept), Janssen’s Remicade (infliximab) and AbbVie’s Humira (adalimumab) have dominated the Plaque psoriasis market for over 10 years.Nevertheless, this is set to change as there has been increasing development of new therapeutics, particularly within the IL-17 and IL-23 classes.

Furthermore, companies are racing to bring their biosimilars to the market. As a result, it will be difficult for any one product to become and remain a market leader in a heavily competitive market.

There are many companies that are striving to enter the Plaque psoriasis market and many of the drugs target moderate and severe Plaque psoriasis patients.However, the most neglected segment is the mild severity.

There are limited treatment options other than topical and small molecule therapeutics and this is a high unmet need.

The latest report "Plaque Psoriasis: Global Drug Forecast and Market Analysis to 2027", provides key metrics for Plaque Psoriasis (Epidemiology, Market Size, Product Pipeline, Key Events, Competitive Analysis) in the seven major pharmaceutical markets (7MM) covered in this report-the US, 5EU (France, Germany, Italy, Spain, and the UK), and Japan-during the forecast period from 2017-2027.

Key Questions Answered
- How will the Psoriasis market landscape in the 7MM (US, France, Germany, Italy, Spain, UK and Japan) change from 2017-2027?
- What are the most promising late-stage pipeline drugs in Plaque Psoriasis?
- How do the clinical and commercial attributes of late-stage pipeline therapies compare with one another and against existing treatment options?
- What are the greatest unmet needs in Plaque Psoriasis? Will the pipeline drugs fulfil these needs of the market?
- What are the largest opportunities in the Plaque Psoriasis landscape?

- Overview of Plaque psoriasis, including epidemiology, etiology, pathophysiology, symptoms, diagnosis, and current management strategies.
- Topline Plaque psoriasis market revenue from 2017-2027. ACOT and major pipeline product sales in this forecast period are included.
- Key topics covered include current treatment options, unmet needs and opportunities, and the drivers and barriers affecting Plaque psoriasis therapeutics sales in the 7MM.
- Pipeline analysis: comprehensive data split across different phases, emerging novel trends under development, synopses of innovative early-stage projects, and detailed analysis of late-stage pipeline products.
- Analysis of the current and future market competition in the global Plaque psoriasis therapeutics market. Insightful review of the key industry drivers, restraints, and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy
The report will enable you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global Plaque psoriasis therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Plaque psoriasis therapeutics market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Enzymes Global Market Report 2021: COVID 19 Growth And Change to 2030

  • $ 5000
  • June 2021
  • 175 pages

Major players in the enzymes market are Sanofi, AbbVie Inc., Alexion Pharmaceuticals Inc, Horizon Pharma, Allergan plc, Pfizer Inc., Vivus, Digestive Care, Leadiant Biosciences, and Roche Holdings AG The ...

  • World
  • Biopharmaceutical
  • Pharmaceutical
  • Industry analysis
  • Cancer Mortality


Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on